Ocata Therapeutics Inc. (OCAT)
Market Closed
28 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
8. 47
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
1.12M Volume
0 Eps
$ 8.47
Previous Close Want to track OCAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ocata Therapeutics Inc. (OCAT) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.51B
Trailing P/E (ttm) -9.21
Forward P/E -
PEG ratio -0.17
Price/Sales (ttm) -
Price/Book (mrq) -117.46
Enterprise Value/Revenue 15,906.57
Enterprise Value/EBITDA -74.4
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 3.06
52-Week high 8.71
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:100
Last split Date 28 Aug 2014
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -220.1%
Operating margin -221.41%
Operational effectiveness
Return on assets -6.06%
Return on equity 2.75%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.92
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.12
Total debt (mrq) -
Total Debt/Equity (mrq) -919.62
Current ratio (mrq) 0.84%
Book value per share (mrq) -0.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
